Comparison of Lymphocyte–CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19

Comparison of Lymphocyte–CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19

<b>Background</b>: In COVID-19 patients, lymphocyte–CRP ratio (LCR) is a promising biomarker for predicting adverse clinical outcomes. How well LCR performs compared to conventional inflammatory markers for prognosticating COVID-19 patients remains unclear, which hinders the clinical tra...

Full description

Bibliographic Details
Main Authors: Alexander Liu, Robert Hammond, Kenneth Chan, Chukwugozie Chukwuenweniwe, Rebecca Johnson, Duaa Khair, Eleanor Duck, Oluwaseun Olubodun, Kristian Barwick, Winston Banya, James Stirrup, Peter D. Donnelly, Juan Carlos Kaski, Anthony R. M. Coates
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Personalized Medicine
Subjects:
lymphocyte–CRP ratio
coronavirus disease 19
C-reactive protein
risk stratification
prognostic risk
Online Access:https://www.mdpi.com/2075-4426/13/6/909

Internet

https://www.mdpi.com/2075-4426/13/6/909

Similar Items